9 Meters Biopharma Inc (NMTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,766 | -36,779 | -61,497 | -27,049 | -24,162 |
| Depreciation Amortization | 1,840 | 52 | 1,538 | 1,089 | 2,533 |
| Accounts payable and accrued liabilities | 2,619 | 1,055 | -2,465 | 125 | 86 |
| Other Working Capital | 661 | 2,233 | 5 | 3,022 | -703 |
| Other Operating Activity | 1,403 | 3,962 | 43,009 | 4,845 | 7,077 |
| Operating Cash Flow | $-37,243 | $-29,478 | $-19,410 | $-17,968 | $-15,169 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -13 | -3 | -12 | -14 |
| Other Investing Activity | 0 | -2,418 | -3,185 | 0 | 0 |
| Investing Cash Flow | $-3 | $-2,431 | $-3,187 | $-12 | $-14 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 21,000 | N/A | 2,500 | 5,000 | 3,345 |
| Common Stock Issued | N/A | 44,010 | 39,676 | 20,737 | 19,243 |
| Other Financing Activity | -1,088 | -2,959 | 13,679 | -8,893 | -2,032 |
| Financing Cash Flow | $19,912 | $41,051 | $55,855 | $16,844 | $20,557 |
| Beginning Cash Position | 46,993 | 37,851 | 4,593 | 5,729 | 356 |
| End Cash Position | 29,659 | 46,993 | 37,851 | 4,593 | 5,729 |
| Net Cash Flow | $-17,334 | $9,142 | $33,259 | $-1,136 | $5,373 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,243 | -29,478 | -19,410 | -17,968 | -15,169 |
| Capital Expenditure | -3 | -13 | -3 | -12 | -14 |
| Free Cash Flow | -37,246 | -29,491 | -19,412 | -17,980 | -15,183 |